acquired immune hemolytic anemia

DBCOND0022249Hemic and Lymphatic Diseases

acquired immune hemolytic anemia is the indication for 8 drugs in DrugBank. It is covered by 8 curated, structured indications.

Also known as
Acquired hemolytic anemias · Acquired hemolytic anemia · Acquired Anemia Hemolytic
Classified under
Indicated drugs

Resolves to

Vocabularies
ICD-10D59SNOMED CT154802007MedDRA10000549UMLSC0002878

What you can answer from here — as of October 04, 2026

8Indicated drugsWith each drug's targets and mechanism
Listed above
8Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1Drug reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for acquired immune hemolytic anemia share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In